# FDA Inspection 1230625 - Novartis d.o.o. - January 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/novartis-doo/a9649b50-4b34-4eda-956b-b7cf72548b65
Source feed: FDA_Inspections

> FDA Inspection 1230625 for Novartis d.o.o. on January 25, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230625
- Company Name: Novartis d.o.o.
- Inspection Date: 2023-01-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1229017 - 2024-02-09](https://www.keypedia.com/records/fda_inspections/novartis-doo/4b799615-fc71-4aaf-b7f7-1d9af3713502)

Company: https://www.keypedia.com/companies/novartis-doo/d4f5147d-097a-4bd5-9ee0-25ff7a6cb638

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c